NCT00758524View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

628

Participants

Timeline

Start Date

September 11, 2008

Primary Completion Date

July 2, 2009

Study Completion Date

July 2, 2009

Conditions
Essential Hypertension
Interventions
DRUG

LCI699

LCI699 oral capsules

DRUG

Eplerenone

Eplerenone oral capsules

DRUG

LCI699-matching Placebo

LCI699-matching placebo oral capsules

DRUG

Eplerenone-matching Placebo

Eplerenone-matching placebo oral capsules

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY